New Benzothiazole-based Thiazolidinones as Potent Antimicrobial Agents. Design, synthesis and Biological Evaluation. 2018

Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.

Thiazole and benzothiazole derivatives, as well as thiazolidinones are very important scaffolds in medicinal chemistry. Literature has revealed that they possess a wide spectrum of biological activities including antimicrobial activity. The goal of this paper is the designing of new benzothiazole based thiazolidinones and the evaluation of their biological activities. The designed compounds were synthesized using classical organic synthesis methods. The antimicrobial activity was evaluated using the method of microdilution. The twelve newly synthesized compounds showed antimicrobial properties. All compounds appeared to be more active than ampicillin in most studied strains and in some cases, more active than streptomycin. Antifungal activity, in most cases was also better than the reference drugs ketoconazole and bifonazole. The prediction of cytotoxicity revealed that the synthesized compounds were not toxic (LD50 350-1000 mg/kg of body weight). Docking studies on the antibacterial activity confirmed the biological results. The twelve new compounds were synthesized and studied for their antimicrobial activity. The compounds appeared to be promising antimicrobial agents and could be the lead compounds for new, more potent drugs. According to the docking prediction, the compounds could be MurB inhibitors.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D052160 Benzothiazoles Compounds with a benzene ring fused to a thiazole ring.

Related Publications

Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
February 2012, European journal of medicinal chemistry,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
July 2005, Bioorganic & medicinal chemistry letters,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
May 2011, Bioorganic & medicinal chemistry,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
January 2015, European journal of medicinal chemistry,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
April 2015, Journal of agricultural and food chemistry,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
January 2012, Zeitschrift fur Naturforschung. C, Journal of biosciences,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
July 2010, European journal of medicinal chemistry,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
January 2020, Medicinal chemistry (Shariqah (United Arab Emirates)),
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
February 2018, Archiv der Pharmazie,
Michelyne Haroun, and Christophe Tratrat, and Katerina Kositsi, and Evangelia Tsolaki, and Anthi Petrou, and Bandar Aldhubiab, and Mahesh Attimarad, and Sree Harsha, and Athina Geronikaki, and Katharigatta N Venugopala, and Heba S Elsewedy, and Marina Sokovic, and Jasna Glamoclija, and Ana Ciric
June 2021, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!